The role of viruses in acute exacerbations of asthma
暂无分享,去创建一个
[1] S. Johnston,et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-&kgr;B and EGFR pathways , 2010, European Respiratory Journal.
[2] S. Johnston,et al. Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.
[3] S. Keleş,et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma , 2010, Mucosal Immunology.
[4] Ying Zhao,et al. CXCR2 Is Required for Neutrophilic Airway Inflammation and Hyperresponsiveness in a Mouse Model of Human Rhinovirus Infection1 , 2009, The Journal of Immunology.
[5] N. Papadopoulos,et al. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] Rosanna Lagos,et al. SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN , 2009, The Pediatric infectious disease journal.
[7] P. Sly,et al. Toll-like receptor 7 function is reduced in adolescents with asthma , 2009, European Respiratory Journal.
[8] Wai-ming Lee,et al. Rhinovirus-induced Major Airway Mucin Production Involves a Novel Tlr3-egfr–dependent Pathway , 2009 .
[9] S. Holgate,et al. Contribution of Bronchial Fibroblasts to the Antiviral Response in Asthma1 , 2009, The Journal of Immunology.
[10] P. Bardin,et al. Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. , 2009, American journal of respiratory cell and molecular biology.
[11] D. Kwiatkowski,et al. Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster , 2009, Thorax.
[12] D. Kwiatkowski,et al. Genetic association study for RSV bronchiolitis in infancy at the 5 q 31 cytokine cluster , 2009 .
[13] E. De Clercq,et al. Selective inhibitors of picornavirus replication , 2008, Medicinal research reviews.
[14] S. Johnston,et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production , 2008, Proceedings of the National Academy of Sciences.
[15] S. Johnston,et al. Deficient interferon in virus‐induced asthma exacerbations , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] J. Ceuppens,et al. Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] M. Nyegaard,et al. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.
[18] D. Proud,et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. , 2008, The Journal of allergy and clinical immunology.
[19] S. Weiland,et al. IRF-1 gene variations influence IgE regulation and atopy. , 2008, American journal of respiratory and critical care medicine.
[20] F. Schelcher,et al. Human and bovine respiratory syncytial virus vaccine research and development. , 2008, Comparative immunology, microbiology and infectious diseases.
[21] M. McGuckin,et al. Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.
[22] S. Johnston,et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages , 2008, Thorax.
[23] R. A. Killington,et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation , 2008, Nature Medicine.
[24] C. Schans,et al. Bronchial mucus transport , 2007 .
[25] S. Phipps,et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. , 2007, Blood.
[26] B. O'connor,et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. , 2007, American journal of respiratory and critical care medicine.
[27] S. Johnston,et al. IFN-γ–induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations , 2007, Journal of Allergy and Clinical Immunology.
[28] J. Blic. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial, F. Tahan, A. Ozcan, N. Koc, in: Eur Respir J, 29. (2007), 91 , 2007 .
[29] D. Broide,et al. Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice1 , 2007, The Journal of Immunology.
[30] S. Johnston,et al. Corticosteroids and β2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements* , 2007, Journal of Biological Chemistry.
[31] Herren Wu,et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. , 2007, Journal of molecular biology.
[32] Yusuke Nakamura,et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. , 2007, American journal of respiratory cell and molecular biology.
[33] W. Teague,et al. Prevalence of viral respiratory tract infections in children with asthma , 2006, Journal of Allergy and Clinical Immunology.
[34] F. Tahan,et al. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial , 2006, European Respiratory Journal.
[35] E. Simões,et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. , 2007, The Journal of pediatrics.
[36] C. P. Van der Schans. Bronchial mucus transport. , 2007, Respiratory care.
[37] H. Kubo,et al. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells , 2006, Respiratory Physiology & Neurobiology.
[38] S. Psarras,et al. Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus‐induced epithelial production of remodelling‐associated growth factors , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[39] S. Johnston,et al. Rhinovirus Replication in Human Macrophages Induces NF-κB-Dependent Tumor Necrosis Factor Alpha Production , 2006, Journal of Virology.
[40] Stephen T Holgate,et al. Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.
[41] B. Nicholas,et al. Shotgun proteomic analysis of human‐induced sputum , 2006, Proteomics.
[42] E. Walters,et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.
[43] S. Johnston. Macrolide antibiotics and asthma treatment. , 2006, The Journal of allergy and clinical immunology.
[44] S. Johnston,et al. Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection , 2006, Respiratory research.
[45] S. Johnston,et al. The effect of telithromycin in acute exacerbations of asthma. , 2006, The New England journal of medicine.
[46] A. Bufe,et al. Impaired virus‐induced interferon‐α2 release in adult asthmatic patients , 2006 .
[47] P. Österlund,et al. TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .
[48] S. Johnston,et al. Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.
[49] Y. Jang,et al. Effect of clarithromycin on rhinovirus-16 infection in A549 cells , 2006, European Respiratory Journal.
[50] S. Johnston,et al. Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.
[51] K. Melén,et al. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. , 2006, Virology.
[52] A. Bufe,et al. Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[53] C. Sousa. Faculty Opinions recommendation of Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. , 2005 .
[54] A. Al-ghonaium,et al. Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses , 2005, Immunity.
[55] O. Ramilo,et al. Respiratory Syncytial Virus Infections: Old Challenges and New Opportunities , 2005, The Pediatric infectious disease journal.
[56] S. Johnston,et al. Toll-Like Receptor 3 Is Induced by and Mediates Antiviral Activity against Rhinovirus Infection of Human Bronchial Epithelial Cells , 2005, Journal of Virology.
[57] P. Gibson,et al. Interleukin-10 gene expression in acute virus-induced asthma. , 2005, American journal of respiratory and critical care medicine.
[58] D. Proud,et al. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[59] F. Maldonado,et al. In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease , 2005, Antimicrobial Agents and Chemotherapy.
[60] R. Karron,et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. , 2005, The Journal of infectious diseases.
[61] H. Donninger,et al. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor , 2005, Journal of medical virology.
[62] S. Johnston,et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.
[63] C. Duckett,et al. Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.
[64] R. Flavell,et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.
[65] Guanghui Hu,et al. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. , 2005, The Journal of allergy and clinical immunology.
[66] D. Matthews,et al. Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor , 2005, Antimicrobial Agents and Chemotherapy.
[67] R. Homer,et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.
[68] Jian Zheng,et al. Induction of mucin secretion from human bronchial tissue and epithelial cells by rhinovirus and lipopolysaccharide. , 2004, Acta pharmacologica Sinica.
[69] F. Schmitz,et al. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways , 2004 .
[70] R. Flavell,et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[72] F. Schmitz,et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Abe,et al. Rhinovirus 16 3C Protease Induces Interleukin-8 and Granulocyte-Macrophage Colony-Stimulating Factor Expression in Human Bronchial Epithelial Cells , 2004, Pediatric Research.
[74] H. Simon,et al. Clinical and immunological effects of low‐dose IFN‐α treatment in patients with corticosteroid‐resistant asthma , 2003, Allergy.
[75] Isabelle Vachier,et al. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. , 2003, American journal of respiratory and critical care medicine.
[76] E. D. de KLERK,et al. Interleukin‐1β and interleukin‐1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non‐asthmatic subjects , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[77] S. Johnston,et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. , 2003, American journal of respiratory and critical care medicine.
[78] R. Wood,et al. FREQUENCY, SEVERITY, AND DURATION OF RHINOVIRUS INFECTIONS IN ASTHMATIC AND NONASTHMATIC INDIVIDUALS: A LONGITUDINAL COHORT STUDY , 2003, Pediatrics.
[79] P. Paré,et al. Characterization of airway plugging in fatal asthma. , 2003, The American journal of medicine.
[80] H. Donninger,et al. Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. , 2003, The Journal of infectious diseases.
[81] J. Bousquet,et al. Clinical and biological heterogeneity in children with moderate asthma. , 2003, American journal of respiratory and critical care medicine.
[82] A. Fendrick,et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. , 2003, Archives of internal medicine.
[83] S. French,et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. , 2003, Journal of immunology.
[84] D. Rogers. The airway goblet cell. , 2003, The international journal of biochemistry & cell biology.
[85] J. Gern. Rhinovirus respiratory infections and asthma. , 2002, The American journal of medicine.
[86] Stephen T Holgate,et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.
[87] Bo Liu,et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. , 2002, Journal of medicinal chemistry.
[88] P. Gibson,et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.
[89] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[90] X. Liu,et al. Activation of NF-kappa B in bronchial epithelial cells from children with asthma. , 2001, Chinese medical journal.
[91] S. Holgate,et al. Rhinovirus infection up‐regulates eotaxin and eotaxin‐2 expression in bronchial epithelial cells , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[92] W. Busse,et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. , 2000, American journal of respiratory and critical care medicine.
[93] Douglas T. Golenbock,et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.
[94] V. Casolaro,et al. Role of NF-κB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection1 , 2000, The Journal of Immunology.
[95] J. V. van Krieken,et al. Experimental rhinovirus 16 infection increases intercellular adhesion molecule‐1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[96] W. Busse,et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. , 2000, The Journal of allergy and clinical immunology.
[97] N. Papadopoulos,et al. Rhinoviruses infect the lower airways. , 2000, The Journal of infectious diseases.
[98] N. Papadopoulos,et al. Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells. , 2000, The Journal of allergy and clinical immunology.
[99] S. Johnston,et al. Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.
[100] P. Stjärne,et al. LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. , 1999, American journal of respiratory and critical care medicine.
[101] H. Boushey,et al. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. , 1999, American journal of respiratory and critical care medicine.
[102] M. Schroth,et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.
[103] F. Hayden,et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. , 1999, JAMA.
[104] S. Johnston,et al. Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.
[105] S. Johnston,et al. RANTES, Macrophage-Inhibitory Protein 1α, and the Eosinophil Product Major Basic Protein Are Released into Upper Respiratory Secretions during Virus-Induced Asthma Exacerbations in Children , 1999, The Journal of infectious diseases.
[106] I. Adcock,et al. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.
[107] S. Johnston,et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. , 1998, American journal of respiratory and critical care medicine.
[108] J. Friedland,et al. Respiratory Syncytial Virus-Induced RANTES Production from Human Bronchial Epithelial Cells Is Dependent on Nuclear Factor-κB Nuclear Binding and Is Inhibited by Adenovirus-Mediated Expression of Inhibitor of κBα , 1998, The Journal of Immunology.
[109] W. Busse,et al. Eosinophils bind rhinovirus and activate virus-specific T cells. , 1998, Journal of immunology.
[110] J. Friedland,et al. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. , 1998, Journal of immunology.
[111] Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. , 1998, Pediatrics.
[112] J. Elias,et al. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. , 1997, The American journal of physiology.
[113] K. Nakayama,et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. , 1997, The American journal of physiology.
[114] Weiliang Tang,et al. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-κB. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[115] M. Yamaya,et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[116] R. Martin,et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.
[117] P. Howarth,et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.
[118] E. D. de KLERK,et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.
[119] J. Wilson,et al. Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.
[120] S. Johnston,et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. , 1997, American journal of respiratory and critical care medicine.
[121] E. D. de KLERK,et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin‐8 in nasal lavage in asthmatic subjects in vivo , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[122] W. Calhoun,et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. , 1997, American journal of respiratory and critical care medicine.
[123] W. Busse,et al. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. , 1996, Journal of immunology.
[124] J. Gwaltney,et al. The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. , 1996, Antiviral research.
[125] J. Elias,et al. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. , 1996, The Journal of clinical investigation.
[126] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.
[127] P. Heymann,et al. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. , 1995, International archives of allergy and immunology.
[128] S. Johnston,et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.
[129] T. Maniatis,et al. NF-κB: A lesson in family values , 1995, Cell.
[130] T. Maniatis,et al. NF-kappa B: a lesson in family values. , 1995, Cell.
[131] W. Busse,et al. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.
[132] S. Johnston,et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. , 1994, American journal of respiratory cell and molecular biology.
[133] K. Nicholson,et al. Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.
[134] P. Holt,et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages , 1993, The Journal of experimental medicine.
[135] R. Garofalo,et al. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. , 1992, The Journal of pediatrics.
[136] P. Holt. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. , 1986, Clinical and experimental immunology.
[137] F. Hayden,et al. Intranasal Interferon-α2, Treatment of Experimental Rhinoviral Colds , 1984 .
[138] F. Hayden,et al. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. , 1984, The Journal of infectious diseases.
[139] G. Scott,et al. PREVENTION OF RHINOVIRUS COLDS BY HUMAN INTERFERON ALPHA-2 FROM ESCHERICHIA COLI , 1982, The Lancet.
[140] C. Reed,et al. Viruses as precipitants of asthmatic attacks in children. , 1974, JAMA.
[141] H. Lambert,et al. Infective Factors in Exacerbations of Bronchitis and Asthma , 1972, British medical journal.
[142] W. Aherne,et al. Pathological changes in virus infections of the lower respiratory tract in children , 1970, Journal of clinical pathology.